Disc Drugs, Inc. (IRON) Discusses ASH Convention Knowledge Updates and Portfolio Progress Together with Anemia and Iron Restriction Packages December 7, 2025 7:30 AM EST
Firm Contributors
John Quisel – CEO, President & Director
William Savage – Chief Medical Officer
Jonathan Yu – Chief Opearating Officer
Convention Name Contributors
Jiale Music – Jefferies LLC, Analysis Division
Thomas Smith – Leerink Companions LLC, Analysis Division
Sean Laaman – Morgan Stanley, Analysis Division
Rick Miller – Cantor Fitzgerald & Co., Analysis Division
Evan Seigerman – BMO Capital Markets Fairness Analysis
Tara Bancroft – TD Cowen, Analysis Division
David Nierengarten – Wedbush Securities Inc., Analysis Division
Stephen Willey – Stifel, Nicolaus & Firm, Included, Analysis Division
Danielle Brill Bongero – Truist Securities, Inc., Analysis Division
Rami Katkhuda – LifeSci Capital, LLC, Analysis Division
Derek Archila – Wells Fargo Securities, LLC, Analysis Division
Martin Auster – Raymond James & Associates, Inc., Analysis Division
Presentation
Operator
Good day, and thanks for standing by. Welcome to Disc Administration Convention Name.
[Operator Instructions]
Please be suggested that right this moment’s convention is being recorded.
I’d now like handy the convention over to your speaker right this moment, John Quisel, CEO. Please go forward.
John Quisel
CEO, President & Director
Good morning, and welcome to the Disc Drugs Administration Name. That is John Quisel talking, CEO right here at Disc, and I will be joined by Will Savage, our Chief Medical Officer; and Jonathan Yu, our Chief Working Officer. We’re presenting from Orlando, the place the 67th Annual Assembly of the American Society of Hematology is underway. We introduced an thrilling first take a look at information from the RALLY-MF trial on the ASH Convention yesterday, which would be the focus of right this moment’s name, together with a few broader company updates on the progress of our portfolio.
Earlier than we get began, I will cowl a couple of preliminaries. We might be making forward-looking statements, and these must be taken
